Thursday, Sep 3, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Piramal Pharma Invests Rs 101 77 Cr In Yapan Bio

Piramal Pharma invests Rs 101.77 cr in Hyderabad-based Yapan Bio

New Delhi: Piramal Pharma on Tuesday said it has invested Rs 101.77 crore in Hyderabad-based Yapan Bio to augment the capabilities of its contract development and manufacturing organisation (CDMO) business. The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment. The investment will allow Piramal Pharma to […]

By PTI
Updated On - 21 December 2021, 04:56 PM
Piramal Pharma invests Rs 101.77 cr in Hyderabad-based Yapan Bio
Representational Image
whatsapp facebook twitter telegram

New Delhi: Piramal Pharma on Tuesday said it has invested Rs 101.77 crore in Hyderabad-based Yapan Bio to augment the capabilities of its contract development and manufacturing organisation (CDMO) business.

The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment.


The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its CDMO business, by broadening its service offerings.

“The expertise found at the Yapan will help Piramal provide existing customers with wider capabilities for developing and manufacturing large molecules. This investment further supports our growth strategy,” Piramal Pharma Chairperson Nandini Piramal noted.

Yapan Bio provides process development, scale-up and cGMP compliant manufacturing of vaccines and biologics/bio-therapeutics, including high containment product classes (up to BSL-2+), recombinant vaccines, RNA/DNA vaccines, gene therapies, monoclonal antibodies, therapeutic proteins, and other complex biologics.

Its FY21 turnover stood at Rs 12.4 crore. The company has already earned revenues of Rs 11.8 crore in the first half of FY22.
“During the past decade, biologics and their accompanying development services are the fastest-growing segments of the CDMO market.

“This investment, coupled with the market-leading capabilities of our Grangemouth, UK site in antibody-drug conjugations and our sterile fill capabilities in Lexington, USA, demonstrates our commitment to growing our service offerings in the large molecule CDMO space,” Piramal Pharma Solutions CEO Peter DeYoung said.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • Hyderabad
  • Piramal Pharma
  • Yapan Bio

Related News

  • BRS sets September 7 deadline to Congress government to withdraw GO 97

    BRS sets September 7 deadline to Congress government to withdraw GO 97

  • BRS demands 6,000 Indiramma houses in Secunderabad Cantonment

    BRS demands 6,000 Indiramma houses in Secunderabad Cantonment

  • Telangana employees keep fingers crossed over long-delayed PRC

    Telangana employees keep fingers crossed over long-delayed PRC

  • Telangana SIR likely to be extended by three weeks

    Telangana SIR likely to be extended by three weeks

Latest News

  • Why are you shielding him?: Rahul Gandhi targets Amit Shah over assault case

    7 minutes ago
  • Anahat Singh stuns World No. 11 Nele Gilis to reach London Squash Classic quarters

    12 minutes ago
  • Indian boxers step up Asian Games preparations with multinational camp in Patiala

    23 minutes ago
  • India sends 21.5 tonnes of relief supplies to flood-hit Nepal

    33 minutes ago
  • India dispatches two more aircraft with relief assistance for Nepal, supporting flood-affected communities

    22 minutes ago
  • IYC, NSUI hold candle march in Delhi seeking justice for 16-year-old rape victim

    56 minutes ago
  • RTC bus rams into parked DCM in Abdullapurmet, 10 injured

    1 hour ago
  • Opinion: The next coronavirus will be AI-designed

    1 hour ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App